Mar 31, 2022 by James HalleyWhy Clovis Oncology Stock Skyrocketed 80% This WeekPositive data regarding its lead drug boosted the company's shares.
Mar 30, 2022 by James HalleyWhy Geron's Shares Rose 23.4% on WednesdayThe late clinical-stage biopharmaceutical company is raising money through a stock offering.
Mar 28, 2022 by James HalleyWhy Axsome Therapeutics Stock Climbed 11.1% on MondayThe company announced that it was buying a therapy from Jazz Pharmaceuticals.
Mar 27, 2022 by James Halley2 Cannabis Stocks That Could Make You RicherFalling share prices present an opportunity to get in on two profitable cannabis companies that continue to grow.
Mar 25, 2022 by James HalleyWhere to Invest $100 Right NowA little bit of money can go a long way with thorough research and smart investments.
Mar 24, 2022 by James HalleyWhy Shares of BioXcel Therapeutics Shot Up 25.4% This WeekInvestors may be anticipating a positive review by the FDA of the company's lead drug candidate.
Mar 23, 2022 by James HalleyWhy Alpha Tau Medical Ltd. Stock Soared 42% on WednesdayThe company is developing a promising type of radiation treatment for solid tumors.
Mar 22, 2022 by James HalleyWhy Invitae Stock Rose 10.7% on TuesdayThe molecular diagnostics company is bouncing back from its two-year low.
Mar 17, 2022 by James Halley3 Medical Stocks That Could Double Your Returns in the Long RunThese stocks have doubled returns over the past five years and look poised to do it again.
Mar 16, 2022 by James HalleyWhy BeiGene Stock Soared 33.7% on WednesdayThe Chinese pharmaceutical company saw a bounce back after positive news from government officials.
Mar 15, 2022 by James Halley2 Top Stocks to Buy in March and Hold ForeverThese two overlooked healthcare stocks are underpriced and provide solid, long-term opportunity.
Mar 12, 2022 by James Halley2 Top Value Stocks to Buy Right NowThese two companies have shown consistent revenue growth over the past decade and solid bottom lines.
Mar 10, 2022 by James HalleyWhy Cellectis Stock Rose 20.7% This WeekInvestors saw a bargain when the stock hit its 52-week low early in the week.
Mar 8, 2022 by James HalleyWhy Viatris Stock Dropped 24% in FebruaryInvestors were unimpressed with the company's middling fourth-quarter earnings report.
Mar 7, 2022 by James HalleyWhy BioNTech Stock Dropped 12.4% in FebruaryInvestors are concerned that the company's revenue will plunge as the need for its COVID-19 vaccine diminishes.
Mar 4, 2022 by James HalleyBuying These 2 Stocks Is a Good Way to Hedge Against a Market CrashThese two companies stand to hold up through recessions because of their business models.
Mar 3, 2022 by James HalleyWhy Organovo Holdings, Inc. Stock Soared 49.7% This WeekThe company's licensing agreement with a Swedish company means an infusion of some much-needed cash for Organovo.
Mar 3, 2022 by James HalleyWhy Smile Direct Club Stock Dropped 15.4% This WeekSmile Direct's budget-cutting efforts haven't had a chance to make a difference yet.
Mar 3, 2022 by James Halley2 Monster Stocks to Buy Without Any HesitationThere are good reasons these two stocks are favored by investors.
Mar 2, 2022 by James HalleyWhy Tritium DCFC Limited Stock Rose 15.7% on WednesdayThe stock gained more than $1 a share before slumping later in the day.
